FLU far more deadly for most U.S. states than Covid-19

Remember when the governors closed nearly all the states for months to fight the Flu in 2018, when high estimates showed 95,000 deaths, and even the average guess was 61,000?

Remember how President Donald Trump reacted in 2019, when that prior year analysis came true, and the Centers for Disease Control (CDC) decided the almost final number was 61,000 deaths, plus or minus 20,000 to 30,000 deaths?

Remember when Trump demanded to know why the CDC had no clue to the actual flu death numbers, despite the agency’s 10,899 employees and budget of $11.1 billion?

You can’t remember what didn’t happen, but the disaster of home imprisonment for hundreds of millions of Americans will long be recalled as record fear-mongering, more suited to electioneering than providing our people the truth.

…from a talented friend

Unfortunately, the President usually listens to the wrong advisors, and rarely reviews the actual statistics that might refute their talking points.

For example, in a recent interview in the Lincoln Memorial, he mused that many other countries kept their businesses open and didn’t force everyone to stay at home. He said they did the wrong thing by not closing, or re-opening too soon.

He mentioned Sweden and Japan. Sweden has been repeatedly castigated by the American Press for putting its citizens in danger by not closing stores and factories, and allowing residents to go forth in the great outdoors.

The table we assembled at the end of this blog lists the Covid-19 deaths by million, total deaths and cases by million yesterday for the states and most nations. Flu cases are only those patients seen by a doctor or hospital. Actual cases were much higher and included those who self-medicated, worked through the illness, or ignored symptoms.

By contrast, Covid-19 cases in the U.S. are either those presumed to have the virus, or were tested positive for the virus, regardless of symptoms or recovery. While about 96% of Covid-19 cases require no hospitalization, they are still continually reported as active cases, and never removed from the CDC reports, boosting perception of a larger infection rate than actual.

Sorted by the death rate, our table allows comparison of how well the pandemic was contained, and it paints an ugly picture for many states, especially New York, where daily press briefings by its governor hid a disaster that could only be properly attributed to incompetence, primarily in New York City.

New York state has 1,268 deaths per million residents. Compare that to Trump-target Sweden with 274 deaths or Japan with four deaths per million citizens!

New Jersey has suffered 888 deaths per million, Connecticut – 697, Massachusetts – 586, Louisiana – 431, Michigan – 407, Rhode Island – 323. Each of those states has a higher rate than one of the CDC estimates of U.S. flu deaths in 2018, the last year of verified data.

Across the nation the death per million average was 211 as of yesterday. Excluding New York it would be 170.

The President also trumpeted the accomplishment of performing more virus tests than South Korea, ignoring reality – endless testing won’t stop deaths. Instead, he should have credited South Korea with its five deaths per million citizens, a stunning 1/234th of New York and 1/42d the U.S. average.

And Trump should confront those unmasked health bureaucrats that flank him on press briefings and ask questions like these:

Explain how a “communist/socialist/backward/dictatorship” like Russia has a Covid-19 death rate of just nine, versus the lowest for any U.S. state – Alaska – which has 12 deaths per million?

How does a collapsing dictatorship like Cuba manage only a virus death rate of six?

Are you surprised that densely populated Egypt, which gets billions in foreign aid from the U.S. has a rate of just four deaths, versus New York’s 1,268?

Finally, how can one of the poorest nations on earth and second most populous – India – manage just one death per million?

Examine the following table:

  • Decide for yourself if hiding at home worked, and ponder why four states – New York, New Jersey, Michigan and Massachusetts – represent nearly 60% of all deaths in the 50 states.
  • Is reporting both confirmed and probable deaths – as ordered by the CDC on April 15 without any certification – the correct way to compile data affecting hundreds of millions.
  • Why has third-world Africa virtually escaped the pandemic with just 1,848 total deaths in a continent of 1.2 billion.
  • Why is the death rate in Massachusetts higher than Spain or Italy, while both nations are portrayed as suffering the worst infections worldwide by the media?
  • How can Texas have only 889 deaths, while New York – with 8 million less population – totals 24,874?

Deaths/ Total Cases/
Million Deaths Million
New York 1,268 24,874 16,509
New Jersey 888 7,886 14,348
Connecticut 697 2,495 8,177
Belgium 684 7,924 4,337
Massachusetts 586 4,004 9,969
Spain 544 25,428 5,311
Italy 481 29,079 3,505
Louisiana 431 2,012 6,291
UK 423 28,734 2,807
Michigan 407 4,049 4,394
France 381 24,895 2,584
Rhode Island 323 341 9,135
Netherlands 297 5,082 2,379
Flu USA (high) 290 95,000 83,105
Sweden 274 2,769 2,250
Ireland 267 1,319 4,409
Pennsylvania 221 2,832 4,069
Maryland 219 1,317 4,399
Switzerland 206 1,784 3,464
Illinois 204 2,618 4,797
Indiana 188 1,246 3,003
Delaware 186 177 5,485
Flu USA (avg.) 186 61,000 63,205
Luxembourg 153 96 6,115
Colorado 152 842 3,008
Flu USA (low) 140 46,000 54,812
Georgia 117 1,204 2,826
Washington 115 837 2,163
Portugal 104 1,063 2,503
Canada 102 3,842 1,606
Mississippi 101 303 2,526
Nevada 90 262 1,879
Ohio 89 1,040 1,711
Ecuador 89 1,569 1,807
Denmark 85 493 1,669
Vermont 83 52 1,443
Germany 82 6,866 1,978
Virginia 81 684 2,317
Minnesota 76 419 1,205
Iran 75 6,277 1,174
New Mexico 72 151 1,840
Florida 68 1,399 1,791
Austria 67 600 1,734
N. Hampshire 64 86 1,874
Missouri 62 377 1,385
Oklahoma 61 238 1,014
Iowa 60 188 3,098
Alabama 60 292 1,624
Wisconsin 59 339 1,378
California 57 2,215 1,403
Kentucky 57 253 1,155
South Carolina 55 275 1,337
Arizona 52 362 1,244
Kansas 51 147 1,785
Slovenia 47 97 692
Panama 46 200 1,668
North Carolina 43 439 1,167
Maine 43 57 889
Romania 43 818 702
Finland 43 240 961
Nebraska 41 78 3,103
Turkey 41 3,461 1,514
N. Macedonia 41 85 729
Estonia 41 55 1,284
Peru 39 1,286 1,393
Norway 39 214 1,454
Idaho 38 64 1,221
Hungary 36 351 314
North Dakota 33 25 1,583
Brazil 33 7,106 483
Texas 32 889 1,156
Tennessee 32 210 1,981
Dominican Rep. 32 346 759
Iceland 29 10 5,272
Oregon 27 109 657
West Virginia 27 50 659
Israel 27 234 1,876
Liechtenstein 26 1 2,151
Arkansas 25 76 1,147
South Dakota 24 21 3,044
Bosnia and Herzegovina 24 78 587
Serbia 23 197 1,094
Czechia 23 251 728
Mayotte 22 6 2,515
Croatia 19 80 512
Aruba 19 2 937
Poland 18 698 370
Mexico 17 2,154 182
Lithuania 17 46 521
Utah 16 50 1,699
Montana 15 16 437
Cayman Islands 15 1 1,126
UAE 14 137 1,489
Greece 14 146 253
Chile 14 270 1,080
Montenegro 13 8 514
Armenia 13 39 846
Hawaii 12 17 436
Wyoming 12 7 1,007
Alaska 12 9 498
Bulgaria 11 78 238
Belarus 11 103 1,851
Algeria 11 465 106
Albania 11 31 279
Russia 9 1,356 995
Kuwait 9 40 1,236
Ukraine 7 303 282
Colombia 7 340 151
Bolivia 7 76 137
Philippines 6 623 87
Cuba 6 69 147
Argentina 6 249 106
Uruguay 5 17 189
Slovakia 5 25 259
Saudi Arabia 5 191 823
S. Korea 5 252 211
Morocco 5 179 137
Tunisia 4 42 86
Qatar 4 12 5,620
New Zealand 4 20 308
Liberia 4 18 33
Lebanon 4 25 108
Japan 4 487 118
Egypt 4 436 67
Australia 4 95 268
Singapore 3 18 3,210
Malaysia 3 105 196
Indonesia 3 864 42
French Guiana 3 1 445
China 3 4,633 58
Azerbaijan 3 26 196
Suriname 2 1 17
South Africa 2 131 114
Somalia 2 35 48
Pakistan 2 476 95
Oman 2 12 516
Maldives 2 1 1,001
Kyrgyzstan 2 10 127
Kazakhstan 2 29 216
Iraq 2 98 58
Georgia 2 9 149
Gabon 2 5 151
El Salvador 2 12 86
Djibouti 2 2 1,130
Congo 2 10 43
Cameroon 2 64 78
Brunei 2 1 315
Afghanistan 2 90 74
Togo 1 9 15
Sierra Leone 1 9 22
Paraguay 1 10 56
Niger 1 36 31
Mali 1 29 29
India 1 1,452 33
Costa Rica 1 6 146
Bangladesh 1 182 62
Sudan 1 41 15
Jordan 1 9 46
Guatemala 1 17 39
Eswatini 1 1 100
Thailand 1 54 43
Nicaragua 1 5 2
Haiti 1 9 8
Guinea 1 9 130
Equatorial Guinea 1 1 225
Senegal 1 10 76
Ivory Coast 1 17 53
Ghana 1 18 88
Chad 1 10 7
Hong Kong 1 4 139
Guinea-Bissau 1 1 131
Venezuela 0 10 13
Nigeria 0 87 12
Libya 0 3 9
Kenya 0 24 9
Gambia 0 1 7
DRC 0 34 8
Botswana 0 1 10
Zimbabwe 0 4 2
Uzbekistan 0 10 65
Tanzania 0 16 8
Tajikistan 0 3 24
Taiwan 0 6 18
Zambia 0 3 7
Syria 0 3 3
Mauritania 0 1 2
Malawi 0 3 2
Myanmar 0 6 3
Burundi 0 1 1
Yemen 0 2 0
Angola 0 2 1
Ethiopia 0 3 1

Full report of the 2017-2018 season burden and influenza illness and burden of influenza illness prevented by vaccination in the United States

Who is thwarting an intelligent Covid-19 response?

Are “experts” pushing one Covid-19 treatment over another?

How do drug companies avoid offering Americans lower prices?

Does PA Gov. Wolf want 5.2 million citizens to suffer endlessly, because of coronavirus standards from nanny Health Secretary?

“Right now Medicare is determining that if you (a doctor) have a Covid-19 admission to the hospital, you get $13,000. If that Covid-19 patient goes on a ventilator you get $39,000, three times as much. Nobody can tell me after 35 years in the world of medicine that sometimes those kinds of things impact on what we do,” Minnesota Senator Dr. Scott Jensen explained.

“The Centers for Disease Control and Prevention (CDC) is encouraging American doctors to over-count coronavirus deaths across the US, he added, showing a 7-page document coaching him to fill out death certificates with a Covid-19 diagnosis without a lab test to confirm the patient actually had the virus,” he said.

“…under the CDC guidelines, a patient who died after being hit by a bus and tested positive for coronavirus would be listed as having presumed to have died from the virus, regardless of whatever damage was caused by the bus,” he added.

Some have called the governor of Pennsylvania a sheep in wolf’s clothing (Thomas Westerman Wolf), and others describe him as a snotty rich guy, who went to private schools (The Hill School), and has no clue about how average folks live.

Both assessments appear true to me.

Dr. Levine has a “bad hair day”

However, when a book-smart governor (M.Phil from University of London) teams up with an equally education-inebriated anesthesiologist named Dr. Rachel Levine (Belmont Hill School and Harvard College), it gets even worse – an entire state may kiss its prosperity goodbye forever.

Transparency: I live  in Montgomery County, PA, one of 840,000 citizens bordering northwest Philadelphia. I grew up in Kensington, the poorest neighborhood in that city of not always brotherly love.

Today, I can’t legally escape my suburban home, because of the Governor and Levine, his Secretary of Health, who have become partners to impose onerous Covid-19 (Wuhan Virus, Coronavirus, China Virus) regulations that may be for the rest of my life at age 78.

June Beetle

Is it time to move to California or South Carolina, where the beaches are open and folks in government have leaders who use at least half their brains? Even Georgia sounds tempting, despite those pesky June beetle bugs.

Tom Wolf has an “essential” barber?

Wolf may be the dumbest Pennsylvania governor in history.

When deciding on “essential services”, the governor banned online car sales, perhaps not understanding that keyboards cannot be directly connected to auto showrooms, and viruses don’t travel through long wires to a computer.

While the rest of the state is missing its rums and cokes, Levine and Wolf can still enjoy their favorite vintage wine.

He closed all the state liquor stores, including curbside service, but continued to allow unlimited wine sales in supermarkets (for the better class of drunks?).

In a stark moment of reality he also permitted grocery store beer sales, because someone probably described the results of tar and feathers on even a wolf’s naked body. No beer means fast revolution, and aren’t we trying to “flatten the curve” to avoid riots and such?

Levine and Wolf’s biggest mutual sin is their plan to keep Southeaster Pennsylvania a possibly perpetual stay-at-home destination.

The map below shows all regions of the state. Every county will open within two weeks, including where Wolf and Levine go at night. Some freedom for all, except the Southeast – where I live along with 5.2 million other in-home incarcerated citizens.

Montgomery County Commissioner Dr. Valerie Arkoosh, DO, – another not-so-bright bulb – seemed almost gleeful in a recent television interview, explaining the criterion to reopen the SE region.

This will also be viewed as a regional exercise. That is critically important because we all know that this virus doesn’t care about any borders. We know our workforce travels back and forth between counties, she said.

Dr. Valerie Arkoosh

Arkoosh said the requirement is that in each county only 50 reported cases per 100,000 residents will be allowed for an entire 14-day period. If any county goes above that 50 total for two weeks, the region will remain in shutdown. If any single county meets the goal they can’t open unless all the counties in the region do the same.

Does this sound like announcing Nap Time in kindergarten?

For Montgomery County’s 831,000 residents that means a daily average of no more than 30 cases total at various testing centers.

The County’s daily total this past Sunday was 129 cases, which drops the following 13 days to average about 20 cases to meet the Phase 2 standard. In recent weeks the average has been 187 cases daily, making a 20-per-day result seemingly impossible.

Oddly, the first release of Levine and Wolf’s requirements indicated 50 cases each day for 14 days, and not one day exceeding that. When questioned, Levine said she meant 50 cases total for two weeks, and that’s where things stand today.

The federal government is only requiring a downward trajectory for two weeks.

There is another flaw – a big one – in using new cases as a criterion to just begin returning to normal life. Of the 129 cases reported in Montgomery County on Sunday, only 14 were hospitalized. The other 115 went home, but they still count against the threshold of averaging 30 cases daily to move out of the current Red Phase.

In recent findings, New York state had an estimated 2.7 million recovered active cases, so Pennsylvania should have 1.8 million – all of them unreported by testing. By that estimate, Montgomery County alone has some 140,000 unreported, recovered cases so far.

The regulations apply to all counties, and below is the breakdown of goals versus actual in the SE region. Remember that every county has to achieve these results or all the counties will continue in the red phase.

Berks County
2019 population: 421,164
Population / 100,000: 4.21164
Current Numbers (4/24/20): 14 day – 1,517, Daily Average – 108
Target Numbers: 14 day – 211, Daily Average – 15
Deficit – 93 daily active tests. 14-day: 1,309

Bucks County
2019 Population: 628,270
Population / 100,000: 6.2827
Current Numbers (4/24/20): 14 day – 1,525, Daily Average – 109
Target Numbers: 14 days – 314, Daily Average – 22
Deficit – 87 daily active tests. 14-day: 1,218

Chester County
2019 Population: 524,989
Population / 100,000: 5.24989
Current Numbers (4/24/20): 14 day – 736, Daily Average – 53
Target Numbers: 14 days – 262, Daily Average – 19
Deficit – 34 daily active tests. 14-day: 475

Delaware County
2019 Population: 566,747
Population / 100,000: 5.66747
Current Numbers (4/24/20): 14 day – 2,126, Daily Average – 152
Target Numbers: 14 days – 283, Daily Average – 20
Deficit – 132 daily active tests. 14-day:1,848

Lancaster County
2019 Population: 545,724
Population / 100,000: 5.45724
Current Numbers (4/24/20): 14 day – 1,017, Daily Average – 73
Target Numbers: 14 days – 273, Daily Average – 19
Deficit – 54 daily active tests. 14-day: 756

Montgomery County
2019 population: 830,915
Population / 100,000: 8.30915
Current Numbers (4/24/20): 14 day – 2,612, Daily Average – 187
Target Numbers: 14 day – 415, Daily Average – 30
Deficit – 157 daily active tests. 14-day: 2,058

Philadelphia County
2019 population: 1,584,064
Population / 100,000: 15.84064
Current Numbers (4/24/20): 14 day – 8,286 Daily Average – 592
Target Numbers: 14 day – 792, Daily Average – 57
Deficit – 535 daily active tests. 14-day: 7,490

Schuylkill County
2019 population: 141,359
Population / 100,000: 1.41359
Current Numbers (4/24/20): 14 day – 232 Daily Average – 17
Target Numbers: 14 day – 71, Daily Average – 5
Deficit – 12 daily active tests. 14-day: 168

Total Southeastern Pennsylvania Region
2019 population: 5,243,232
Population / 100,000: 52.43232
Current Numbers (4/24/20): 14 day – 18,051 Daily Average – 1,291
Target Numbers: 14 day – 2,622, Daily Average – 187
Deficit – 1,104 daily active tests. 14-day: 15,456

All of the SE counties would have to each eliminate their deficits in order to enter Phase 2 (Yellow), which still doesn’t open schools, bars, restaurants, or allow gatherings of more than 25 persons.

There is no word yet from Levine and Wolf on how we will enter the Green phase, which lifts nearly all restrictions, except CDC rules, also unannounced.

The Southeast region has the most testing, most urban city population, and yet the hospitalized cases seem to average about 10% of active cases, and these totals include those both tested and observed as having the virus.

Deaths in Pennsylvania – now either from testing or mere observation by recently diluted CDC rules – totaled 19 on Sunday in a population of more than 12 million. Yesterday was 37.

It’s a problem for me to imagine how Secretary of Health Levine can relate to average working Pennsylvanians.

For example, she regularly appears on television to reassure residents and provide them with updates and health guidelines. In a recent interview Levine described her job:

My day is busy. I get here at 7 and prepare for my day. Our meeting starts at 8, where first I talk with my team for an hour, and then I go and speak with the senior staff of the governor’s office. And then the senior staff, and I, and the FEMA director have a meeting and then it goes from there.

Many meetings, much sitting, talking, earning salary of $600 a day:

I have a daily press conference … sometimes by myself or with the governor to update the public on the status of COVID-19 in Pennsylvania and the response of our administration. I often speak with legislators and other stakeholders. And then we have a 5 o’clock sum-up meeting till 6. And then I go home and do emails.

While the rest of us are stalked by the “stay home” police, Levine is exempt:

No stay at home. And right now it is seven days a week. So we’ve been at this pace for a while. We’re going to do whatever is possible, whatever it takes to protect the public health of Pennsylvania.

If I had any hope that she would ease the testing insanity, this dashed it:

We’re working on expanding testing. So that is testing for priority populations such as health care workers, nursing homes, etc., to our public health laboratory. But then we also have worked with hospitals and health systems to [set] up testing centers.

And a lot of those tests are either done by the health system or through the commercial laboratories such as Quest or LabCorp.

The more testing, the more active (non-hospitalized) cases, and the longer it will take for SE Pennsylvania to open, if ever.

Levine wants everyone to know that life is tough at the top, even when you can go and do what you wish:

I’m trying to get enough sleep and I’m trying to eat well as best I can. I’m trying to practice what my message is, which is stay calm. I can’t stay home because I have to be here, but staying safe.

But really, I’m not going out anywhere except here and then home. So not too much exposure outside of here at the Pennsylvania Emergency Management Association. But it is very important to stay calm and focused in the midst of emergencies.

And you know, that’s what I learned in my clinical years during my training and then at my time at Mount Sinai and then Penn State when we would see very ill children and adolescents. In those emergency clinical situations, it’s important to stay calm, and so that’s what I do now.

Rachel should realize that the state’s residents would explain to her -given the chance – that they don’t care how calm she is, or overworked.

They would tell her to change senseless rules and allow us to quickly get back to normal.

For a starter let’s stop counting “active” cases, and just use real hospitalized ones, not manufactured ones.

Then, have her tell us what are the goals for the final (Green) phase, so that officials don’t change them with each new statistic in order to further extend the shutdown.

Finally, Dr. Levine, please stop trying to be our nanny. All that does is make us dislike you more and more.

And would someone tell Levine we really don’t care about platitudes such as the following:

Hope is such an important thing. I think that we have to have hope for the future. I think we have to have hope for the future of our commonwealth in Pennsylvania, hope for the future of our nation.

And in relation to some of the things we’re talking about, hope for the future for the LGBTQ community. I firmly believe that we have made progress. We have been under challenges and faced a lot of challenges with this current administration.

Note to doctor: the real challenges are for the millions enduring this, and not for the folks at the top, who are causing it.

Late breaking good news for the “better” class of folks.: Governor Wolf just announced the opening of golf courses and yacht marinas, as of May 1. All factories, schools, restaurants, office buildings and other activities will remain closed until further notice and citizens are asked to continue cowering in their homes without jobs. (Will the “essential” country club waiters just serve wine, or sneak in a few cocktails at the clubhouse?)

China Set to Patent Gilead’s Experimental Coronavirus Drug

Follow the money! The esteemed investor site The Motley Fool explained this week:
The drug (Remdesivir) could see over $1 billion in sales in the course of the entire coronavirus outbreak, due to the sheer number of patients infected and potentially at risk for the virus. This is assuming the drug can treat up to 500,000 patients and cost little over $2,000 for one course of treatment. 

But who will control the licensing and supply of the drug, now being promoted by the media as the preferred treatment for Covid-19, versus Hydroxychloroquine, a $20 generic?

Remember the lab where the virus probably originated?

“The Wuhan Institute of Virology — based in the Chinese city at the center of the epidemic — has applied for a patent in China for the use of the antiviral drug, known as Remdesivir, in treating Covid-19. The application was made on Jan. 21 together with a military academy,” according to a Feb. 4 statement on the institute’s website.

If the application succeeds, Gilead would need to get Chinese patent owners on board in sales of the drug for treating coronavirus infections outside China, including the United States.

“The good thing in having a patent is that it would lead to cross-licensing situations that give China more bargaining chips in negotiating the licensing fee with Gilead,” Wang Yanyu, a senior partner at AllBright Law Offices in Beijing, explained.

While the politicians in the U.S. were busy closing the Senate and dominating the airwaves with a foregone no at the President’s impeachment trial, China was busy buying up supplies to treat the virus and making this bet on Remdesivir.

“While Gilead’s experimental drug isn’t licensed or approved anywhere in the world, it is being rushed into trials in China on coronavirus patients after showing early signs of being highly effective. It may go into clinical trials in China as early as next week in patients with moderate and severe symptoms of the pathogen,” Merdad Parsey, Gilead’s chief medical officer, said.

In the journal Cell Research Wuhan Institute scientists said Gilead’s Remdesivir, and Hydroxychloroquine, are “highly effective” in laboratory studies at thwarting the coronavirus.

China is capable of manufacturing Hydroxychloroquine, and now wants not only access to Remdesivir, but also worldwide control of the drug.

Gilead will still retain the global rights to market the antiviral medication, once approved, in treating illnesses such as Ebola and SARS, the Wuhan institute said.

If China grants the patent, it will control the use and price of Remdesivir, enabling huge profits from treating a worldwide virus. Gilead’s share from working with China remains unclear at this time, but dividing up a global Remdesivir treatment conservative total of even 100 million patients would yield a $200 billion payoff.

Will Congress, the media or the medical profession censure the company for such a deal?

Unlikely, since Big Pharma spends tens of billions of dollars on ads and other marketing, including direct payments to universities and doctors.

Totals listed below account for payments during the 2018 calendar year that mention Gilead products.

GILEAD SCIENCES INC Payments in 2018 (from Propublica)

26,534 doctors and 131 teaching hospitals

Totals listed below account for payments during the 2018 calendar year that mention this product. If a payment record mentions more than one product, the entire value will be included in each of those products.

Gilead products, number of doctors, and total paid

EPCLUSA               7,487    $4.32M

BIKTARVY             3,937     $2.08M

TRUVADA             3,496     $1.65M

VEMLIDY              3,268     $1.58M

ZYDELIG               1,283     $962K

RANEXA                2,290    $870K

CAYSTON              559       $292K

YESCARTA            233        $218K

LETAIRIS               1,566     $181K

  HARVONI              176        $29,211

Top Doctors Receiving Payments From Gilead in 2018

Pediatric Infectious Diseases


Infectious Disease

Infectious Disease


Internal Medicine

Internal Medicine

Internal Medicine

Transplant Surgery

Geriatric Medicine

Family Medicine

Top Teaching Hospitals Receiving Payments From Gilead in 2018












Report on payments to doctors from all healthcare companies!

A video translated from Chinese:

What is your chance of a fatal Covid-19 infection?

We compiled these charts yesterday to demonstrate total deaths per 1,000, 10,000 and 1,000,000 persons by state and country. Some 193 nations are safer and have a lower mortality than the United States. The higher the number, the more chance of death. Only one nation – San Marino – has more than a one-in-a-thousand chance of dying from the disease.

Deaths/  Deaths/ Deaths/ Deaths/ Deaths/ Deaths/
Country Million 10,000 1,000 State Million 10,000 1,000
San Marino 1,149 11.490 1.14900 New York 933 9.330 0.93300
Belgium 490 4.900 0.49000 New Jersey 473 4.730 0.47300
Andorra 466 4.660 0.46600 Connecticut 315 3.150 0.31500
Spain 437 4.370 0.43700 Louisiana 278 2.780 0.27800
Italy 391 3.910 0.39100 Massachusetts 250 2.500 0.25000
France 302 3.020 0.30200 Michigan 240 2.400 0.24000
UK 237 2.370 0.23700 Rhode Island 142 1.420 0.14200
Sint Maarten 233 2.330 0.23300 Washington DC 140 1.400 0.14000
Netherlands 215 2.150 0.21500 Illinois 101 1.010 0.10100
Switzerland 161 1.610 0.16100 Pennsylvania 97 0.970 0.09700
Sweden 152 1.520 0.15200 Washington 87 0.870 0.08700
Ireland 124 1.240 0.12400 Indiana 85 0.850 0.08500
USA 123 1.230 0.12300 Maryland 81 0.810 0.08100
Channel Islands 121 1.210 0.12100 Colorado 76 0.760 0.07600
Luxembourg 117 1.170 0.11700 Delaware 71 0.710 0.07100
Bermuda 80 0.800 0.08000 Georgia 66 0.660 0.06600
Monaco 76 0.760 0.07600 Vermont 61 0.610 0.06100
Isle of Man 71 0.710 0.07100 Mississippi 53 0.530 0.05300
Portugal 70 0.700 0.07000 Nevada 53 0.530 0.05300
Iran 61 0.610 0.06100 Ohio 40 0.400 0.04000
Denmark 61 0.610 0.06100 Florida 38 0.380 0.03800
Germany 55 0.550 0.05500 Wisconsin 38 0.380 0.03800
Saint Martin 52 0.520 0.05200 Oklahoma 36 0.360 0.03600
Austria 50 0.500 0.05000 Virginia 33 0.330 0.03300
Canada 42 0.420 0.04200 Missouri 33 0.330 0.03300
Slovenia 36 0.360 0.03600 Alabama 33 0.330 0.03300
British VI 33 0.330 0.03300 Kentucky 33 0.330 0.03300
Martinique 32 0.320 0.03200 Kansas 32 0.320 0.03200
Antigua/Barbuda 31 0.310 0.03100 New Hampshire 31 0.310 0.03100
Norway 30 0.300 0.03000 California 30 0.300 0.03000
Estonia 30 0.300 0.03000 Idaho 27 0.270 0.02700
Panama 28 0.280 0.02800 Arizona 26 0.260 0.02600
Ecuador 27 0.270 0.02700 New Mexico 26 0.260 0.02600
Iceland 26 0.260 0.02600 Maine 26 0.260 0.02600
Liechtenstein 26 0.260 0.02600 South Carolina 24 0.240 0.02400
Turks & Caicos 26 0.260 0.02600 Iowa 24 0.240 0.02400
Turkey 24 0.240 0.02400 Minnesota 24 0.240 0.02400
North Macedonia 24 0.240 0.02400 Tennessee 22 0.220 0.02200
Romania 23 0.230 0.02300 North Carolina 19 0.190 0.01900
Bahamas 23 0.230 0.02300 Texas 18 0.180 0.01800
Dominican Rep. 21 0.210 0.02100 Oregon 18 0.180 0.01800
Israel 20 0.200 0.02000 Nebraska 15 0.150 0.01500
Hungary 20 0.200 0.02000 Arkansas 13 0.130 0.01300
Guadeloupe 20 0.200 0.02000 North Dakota 13 0.130 0.01300
Aruba 19 0.190 0.01900 Alaska 12 0.120 0.01200
Czechia 17 0.170 0.01700 West Virginia 11 0.110 0.01100
Finland 17 0.170 0.01700 Montana 10 0.100 0.01000
Moldova 17 0.170 0.01700 Utah 9 0.090 0.00900
Barbados 17 0.170 0.01700 South Dakota 8 0.080 0.00800
Bosnia 15 0.150 0.01500 Hawaii 7 0.070 0.00700
Mayotte 15 0.150 0.01500 Wyoming 3 0.030 0.00300
Cayman Islands 15 0.150 0.01500
Serbia 14 0.140 0.01400
Lithuania 13 0.130 0.01300
Brazil 12 0.120 0.01200
Peru 12 0.120 0.01200
Greece 11 0.110 0.01100
Croatia 11 0.110 0.01100
Poland 10 0.100 0.01000
Cyprus 10 0.100 0.01000
Algeria 9 0.090 0.00900
Albania 9 0.090 0.00900
Guyana 9 0.090 0.00900
Montenegro 8 0.080 0.00800
Chile 7 0.070 0.00700
Armenia 7 0.070 0.00700
Malta 7 0.070 0.00700
Mauritius 7 0.070 0.00700
Bulgaria 6 0.060 0.00600
Trinidad/Tobago 6 0.060 0.00600
Curaçao 6 0.060 0.00600
S. Korea 5 0.050 0.00500
Mexico 5 0.050 0.00500
Belarus 5 0.050 0.00500
Honduras 5 0.050 0.00500
Belize 5 0.050 0.00500
UAE 4 0.040 0.00400
Philippines 4 0.040 0.00400
Colombia 4 0.040 0.00400
Morocco 4 0.040 0.00400
Bahrain 4 0.040 0.00400
China 3 0.030 0.00300
Saudi Arabia 3 0.030 0.00300
Australia 3 0.030 0.00300
Ukraine 3 0.030 0.00300
Qatar 3 0.030 0.00300
Malaysia 3 0.030 0.00300
Argentina 3 0.030 0.00300
Cuba 3 0.030 0.00300
Tunisia 3 0.030 0.00300
Latvia 3 0.030 0.00300
Lebanon 3 0.030 0.00300
Bolivia 3 0.030 0.00300
Uruguay 3 0.030 0.00300
Russia 2 0.020 0.00200
Japan 2 0.020 0.00200
Singapore 2 0.020 0.00200
Indonesia 2 0.020 0.00200
Egypt 2 0.020 0.00200
Kuwait 2 0.020 0.00200
Iraq 2 0.020 0.00200
New Zealand 2 0.020 0.00200
Azerbaijan 2 0.020 0.00200
Slovakia 2 0.020 0.00200
Cameroon 2 0.020 0.00200
Djibouti 2 0.020 0.00200
Burkina Faso 2 0.020 0.00200
Jamaica 2 0.020 0.00200
Brunei 2 0.020 0.00200
Liberia 2 0.020 0.00200
Cabo Verde 2 0.020 0.00200
Suriname 2 0.020 0.00200
Oman 1 0.010 0.00100
Costa Rica 1 0.010 0.00100
Georgia 1 0.010 0.00100
Paraguay 1 0.010 0.00100
El Salvador 1 0.010 0.00100
Congo 1 0.010 0.00100
South Africa 0.9 0.009 0.00090
Kazakhstan 0.9 0.009 0.00090
Eswatini 0.9 0.009 0.00090
Pakistan 0.8 0.008 0.00080
Afghanistan 0.8 0.008 0.00080
Niger 0.8 0.008 0.00080
Kyrgyzstan 0.8 0.008 0.00080
Thailand 0.7 0.007 0.00070
Jordan 0.7 0.007 0.00070
Mali 0.7 0.007 0.00070
Bangladesh 0.6 0.006 0.00060
Palestine 0.6 0.006 0.00060
Togo 0.6 0.006 0.00060
Hong Kong 0.5 0.005 0.00050
India 0.4 0.004 0.00040
Guinea 0.4 0.004 0.00040
Guatemala 0.4 0.004 0.00040
Somalia 0.4 0.004 0.00040
Gabon 0.4 0.004 0.00040
Botswana 0.4 0.004 0.00040
Gambia 0.4 0.004 0.00040
Ghana 0.3 0.003 0.00030
Ivory Coast 0.3 0.003 0.00030
Taiwan 0.3 0.003 0.00030
DRC 0.3 0.003 0.00030
Sri Lanka 0.3 0.003 0.00030
Kenya 0.3 0.003 0.00030
Venezuela 0.3 0.003 0.00030
Haiti 0.3 0.003 0.00030
Nicaragua 0.3 0.003 0.00030
Senegal 0.2 0.002 0.00020
Sudan 0.2 0.002 0.00020
Zambia 0.2 0.002 0.00020
Syria 0.2 0.002 0.00020
Zimbabwe 0.2 0.002 0.00020
Mauritania 0.2 0.002 0.00020
Uzbekistan 0.1 0.001 0.00010
Nigeria 0.1 0.001 0.00010
Tanzania 0.1 0.001 0.00010
Libya 0.1 0.001 0.00010
Malawi 0.1 0.001 0.00010
Myanmar 0.09 0.001 0.00009
Benin 0.08 0.001 0.00008
Burundi 0.08 0.001 0.00008
Angola 0.06 0.001 0.00006
Ethiopia 0.03 >0.001 0.00003
Réunion >.03 >0.001 >0.00003
Vietnam >.03 >0.001 >0.00003
Rwanda >.03 >0.001 >0.00003
Gibraltar >.03 >0.001 >0.00003
Cambodia >.03 >0.001 >0.00003
Madagascar >.03 >0.001 >0.00003
French Guiana >.03 >0.001 >0.00003
Equatorial Guinea >.03 >0.001 >0.00003
French Polynesia >.03 >0.001 >0.00003
Uganda >.03 >0.001 >0.00003
Maldives >.03 >0.001 >0.00003
Guinea-Bissau >.03 >0.001 >0.00003
Macao >.03 >0.001 >0.00003
Eritrea >.03 >0.001 >0.00003
Mozambique >.03 >0.001 >0.00003
Sierra Leone >.03 >0.001 >0.00003
Chad >.03 >0.001 >0.00003
Mongolia >.03 >0.001 >0.00003
Nepal >.03 >0.001 >0.00003
Laos >.03 >0.001 >0.00003
Timor-Leste >.03 >0.001 >0.00003
New Caledonia >.03 >0.001 >0.00003
Fiji >.03 >0.001 >0.00003
Dominica >.03 >0.001 >0.00003
Namibia >.03 >0.001 >0.00003
Saint Lucia >.03 >0.001 >0.00003
Grenada >.03 >0.001 >0.00003
Saint Kitts/Nevis >.03 >0.001 >0.00003
St. Vincent >.03 >0.001 >0.00003
Falkland Islands >.03 >0.001 >0.00003
Greenland >.03 >0.001 >0.00003
Montserrat >.03 >0.001 >0.00003
Seychelles >.03 >0.001 >0.00003
Vatican City >.03 >0.001 >0.00003
Papua New Guinea >.03 >0.001 >0.00003
St. Barth >.03 >0.001 >0.00003
Western Sahara >.03 >0.001 >0.00003
Bhutan >.03 >0.001 >0.00003
Carib. Netherlands >.03 >0.001 >0.00003
Sao Tome >.03 >0.001 >0.00003
South Sudan >.03 >0.001 >0.00003
Anguilla >.03 >0.001 >0.00003
Saint Pierre >.03 >0.001 >0.00003
Yemen >.03 >0.001 >0.00003

The lobbyists in the Trump woodpile, or how the President dumped drug price reforms to please Joe Grogan and Pharma

Who is Joe Grogan? Hint: he is not the famous comedian – Joe Rogan.

Here’s the graph of his resume – revolving from industry to government and now the White House – enough to make your head spin from such swinging roles.

Is it possible for any lobbyist from Gilead Sciences to be fair and objective in determining our drug policy? Most of us believe you can put lipstick on a pig, but the beast will still revert to acting and thinking like a pig, and my instinct says Grogan is just a Revlon-enhanced pawn of Pharma’s pen of paid omnivores.

Joe Grogan (left) with Hungarian Foreign Minister Péter Szijjártó

President Donald Trump has done nothing to fulfill his campaign promise of lowering drug prices, and many attribute that failure to advice from Grogan.

The latest Trump stumble is appointing Grogan to the Coronavirus (Covid-19) Task Force. The result is a fox in an already bureaucratic hen house, where members are focused on ultra safety, avoiding failure and – one wonders also – maximizing drug company profits.

For example, why is the task force, pushed by an aggressive Grogan, playing down the use of hydroxicholiquine to treat Covid-19, while seemingly seeking expensive alternatives.

The reason might be that this drug, used around the world and in the United States successfully, is a cheap generic with no room to overcharge and enrich the callous investor class.

Enter, stage right: remdesivir!

In early March, Gilead sought and was subsequently granted an orphan drug designation (from the FDA) for the remdesivir as a potential treatment for COVID-19. Orphan drug designation is granted by the FDA in situations where the disease affects fewer than 200,000 patients in the United States, according to a Gilead press release.

Orphan drug means you can exclude use of generic equivalents for seven years and have a monopoly to fix its cost.

Gilead is not above charging astronomical prices if it gets permission. Two examples: Harvoni, a blockbuster Hepatitis C drug, costs $31,500 and Gilead’s Sovaldi, costs $28,000 – both per month!

Grogan, top health advisor to Trump, could have stopped the FDA giveaway to Gilead, or at least interrupted the President’s endless briefings to explain that it was obvious remdesivir was not orphan, and ultimately could be used on billions of patients, totally disqualifying it for a price-fixing monopoly.

Senator Bernie Sanders – who has finally stopped campaigning – heard about the FDA rollover to Gilead, and loudly ripped the agency and the drug company for their arrogant attempt to enrich Grogan’s former employer.

Gilead quickly relented and asked to withdraw the fake orphan tag in this press release:

Gilead has submitted a request to the U.S. Food and Drug Administration to rescind the orphan drug designation it was granted for the investigational antiviral remdesivir for the treatment of COVID-19 and is waiving all benefits that accompany the designation. Gilead is confident that it can maintain an expedited timeline in seeking regulatory review of remdesivir, without the orphan drug designation. Recent engagement with regulatory agencies has demonstrated that submissions and review relating to remdesivir for the treatment of COVID-19 are being expedited.

In its report on the 53 patients studied for use of remdesivir, Gilead revealed these adverse effects:

A total of 32 patients (60%) reported adverse events during follow-up. The most common adverse events were increased hepatic enzymes, diarrhea, rash, renal impairment, and hypo-tension. In general, adverse events were more common in patients receiving invasive ventilation. A total of 12 patients (23%) had serious adverse events. The most common serious adverse events — multiple-organ-dysfunction syndrome, septic shock, acute kidney injury, and hypo-tension — were reported in patients who were receiving invasive ventilation at baseline.

Four patients (8%) discontinued remdesivir treatment prematurely: one because of worsening of preexisting renal failure, one because of multiple organ failure, and two because of elevated aminotransferases, including one patient with a maculopapular rash.

Have government officials been playing down one drug – hydroxicholiquine – in favor of another one, not because of highest efficacy and safety, but because one will enrich Big Pharma and the other won’t.

Grogan’s graduation from Gilead to the White House violated Trump’s campaign-trail pledge to “drain the swamp” of D.C. corruption. He promised his administration would refrain from hiring lobbyists.

In 2017 White House budget director and ex-congressman Mick Mulvaney ignored the swamp-draining pledge and hired Grogan, who was then Gilead’s head of federal affairs. In the long run lobbyists took dozens of jobs in the Trump administration.

To watchers of Mulvaney it was no surprise he liked paid petitioners.

In April 2018, Mulvaney told a room of banking industry executives and lobbyists that as a U. S. Representative, he refused to take meetings with lobbyists unless they contributed to his political campaigns:

If you are a lobbyist who never gave us money, I did not talk to you. If you are a lobbyist who gave us money, I might talk to you.

He was later named acting Chief of White House Staff.

After his hiring, Mulvaney protege Grogan soon seemed to control the administration’s drug pricing efforts, leading meetings of the Drug Pricing and Innovation Working Group.

Grogan invited Robert Shapiro, a member of a Gilead advisory board, to give a presentation to one meeting. The group never issued formal recommendations, but Business Insider said these were some of the highlights of sessions:

  • The group wants to extend overseas patents, which would give drug makers longer periods of exclusivity before generic drugs come to the market.
  • It also wants … changes to the regulatory system and reimbursements for medications.
  • Members have chatted about value-based pricing, a concept in which prescriptions are paid for based on how well they work, rather than on a per-pill basis.
  • The group considered setting up Treasury bonds to pay for expensive treatments that have led to only the sickest patients receiving treatment because of the high cost in recent years.
  • Other documents from the working group discuss being more lenient on clinical trials, which the FDA uses the data from to vet experimental drugs.

Some text in the working group’s documents was taken directly from papers written by the lobby group Pharmaceutical Research and Manufacturers of America.

In a few cases in recent years Grogan has been almost favorable to consumers, but his past adhesion to the drug industry, and continued favoritism, should disqualify him as an honest broker.

Meanwhile, Mulvaney has just been exiled to Northern Ireland, where blarney is more acceptable, Grogan remains in power, and Big Pharma awaits rewards.

Does “Big Pharma” oppose prescribing Hydroxychloroquine because it’s a GENERIC – that costs $14.33 for 30 tablets

Two deadly viruses and their prescription drug prices:

AIDS – BIKTARVY is a complete HIV-1 treatment that combines 3 powerful medicines into 1 small pill, taken once a day with or without food. The COSTCO price for Biktarvy oral tablets (50 mg-200 mg-25 mg) is $3,202.66 for a supply of 30 tablets. Prices are for cash-paying customers only, and are not valid with insurance plans. Biktarvy is available as a brand name drug only, a generic version is not yet available.

COVID-19 – 37% of 6,227 doctors across 30 countries felt the drug Hydroxychloroquine was the “most effective therapy” out of 15 options in treating coronavirus. COSTCO cash price is $14.33 for 30 tablets of this generic drug. If you have money to burn, a brand name version is available at $317.64 for the same dosage at COSTCO.

The outcry against a low cost COVID-19 treatment has begun in the United States – the country with the most expensive drugs in the world, a place where a patient spending $38,472 a year on an AIDS prescription is just big business as usual.

“Hydroxychloroquine needs months of clinical trials,” the government health brain trust maintains, despite it being safely used around the world for decades to treat various ailments.

It could have serious side effects if administered improperly,” the American Medical Association declares, neglecting to mention that even too much aspirin at once can quickly kill you.

Hydroxychloroquine was approved for medical use in the United States in 1955. It is on the World Health Organization’s List of Essential Medicines, the safest and most effective medicines needed for a health system. In 2017, it was the 128th-most-prescribed medication in the United States, with more than five million prescriptions, according to Wikipedia.

If we follow the money, we learn why supplicants of Big Pharma discredit any drug that doesn’t reap huge profits by overpricing essential drugs in our for-very-big-profits health system.

Hydroxychloroquine is cheap, easy to produce, long in use, and judged effective enough that other nations prefer it as the major treatment for coronavirus.

This drug has been prescribed in 72% of coronavirus cases in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, and 23% in the United States, where about 19% of physicians have already used it for high-risk patients, and 8% for the low-risk ones.

Those same top government experts, we watch on tv daily, are the same ones who were involved in fighting AIDS. That epidemic’s solutions have resulted in billions of dollars spent on incredibly costly drugs and fabulous profits for healthcare system investors..

The current efforts to denigrate low-cost solutions to the COVID-19 crisis, even include the once independent New York Times:

The president’s advocacy of the anti-malarial drug has created tensions in his administration,
and fears among doctors that it could unnecessarily expose patients to risks.

You can’t tell that lie to the pollster of the following Sermo global survey, showing doctors’ preferences.

Sermo CEO Peter Kirk explained:

Physicians should have more of a voice in how we deal with this pandemic and be able to quickly share information with one another and the world,” he said.

With censorship of the media and the medical community in some countries, along with biased and poorly designed studies, solutions to the pandemic are being delayed.

The survey also found that 63% of U.S. physicians believe restrictions should be lifted in six weeks or more, and that the epidemic’s peak is at least 3-4 weeks away.

In addition, the survey also reported that 83% of global physicians anticipate a second global outbreak, including 90% of U.S. doctors, but only 50% of physicians in China.

On average, U.S. coronavirus testing takes 4-5 days, while 10% of cases take longer than seven days. In China, 73% of doctors reported getting rest results back in 24 hours.

Other governments are not questioning the use of Hydroxychloroquine or waiting to use it until months or years of blind tests are completed.

Most nations have single-payer healthcare, which seeks the least expensive and most effective drugs for taxpayers. By contrast, the U.S. spends more than any other country for a fleece-the-public health system that nearly always benefits investors first, even if that impoverishes the rest of us, or ignores simple, inexpensive solutions.

Up to the minute Coronavirus stats

Coronavirus “rescue” bill sends $11 billion to develop Africa, instead of restoring huge cuts to programs for Americans

While critics of the Coronavirus Aid, Relief and Economic Security Act (CARES Act) bring up the $25 million for the John F. Kennedy Center for the Performing Arts, there is virtually no reporting of the $10.8 billion authorized for three African development banks.

African Development Bank Building

Funding for the Kennedy Center came with the stipulation it would help deal with fallout from the coronavirus pandemic. There is no such restriction connected to the huge sums for the African Development Fund (ADF), the African Development Bank (AfDB) and the International Development Association (IDA)..

The ADF and the AfDB are two related organizations that are supposed to fund development and poverty eradication efforts in Africa. The IDA is a subsidiary of the World Bank that lends money to poor countries and then forces changes in their financial and social structures to promote privatization.

These agencies have been criticized for failing to be effective. For example, the average Sub-Saharan African lives on just $1 a day, while developers of infrastructure often build projects of little value to these mostly tribal countries.

In February David Malpass told the World Bank/International Monetary Fund (IMF) forum that the Asian Development Bank (ADB), the AfDB, and the European Bank for Reconstruction and Development (EBRD) have a “tendency to lend too quickly and thereby aggravate the problem of country debt”. There are also hedge fund connections to create “securitization” of loans, including paid arrangements with Mariner Investment Group.

The President of the World Bank Group, Malpass criticized the AfDB specifically for its activities in Nigeria and South Africa. He urged “greater coordination among international financial institutions to coordinate lending and maintain high standards of transparency”.

Lawrence Summers

How did all this money become part of the virus bill?

The Center for Global Development (CGD) told Nancy Pelosi and Mitch McConnell in a letter that they must include funding for these groups, claiming that even after the virus is under control in the United States, it could come back if it surges in Africa.

Former Treasury Secretary Lawrence H. Summers heads the CGD board. A prominent member of the Trilateral Commission, Summers served as Treasury Secretary under President William Clinton. Other CGD board members include Judy Woodruff, Managing Editor of the PBS NewsHour. CGD was founded in November 2001 by another Trilateral leader, Fred Bergsten, ex-director of the Peterson Institute.

There are 115 total reported deaths from the virus thus far in the entire continent of Africa among its 1.216 billion population. That compares to 1,342 deaths in just New York State with 19.54 million residents. Africa is the last place to send aid to fight a virus which has killed 39,000 worldwide.

What else could Congress have done with that $10.8 billion that went to the international development banks?

We could have replaced the $9.2 billion cut from the budget for the Department of Education, which would allow us to:

In addition, we could restore $1.6 billion in cuts to the Department of the Interior, which eliminated 4,000 jobs, ended  funding for 49 National Historic Sites and decreased funding for land acquisition and the Cooperative Endangered Species Conservation Fund.

The following is the relevant text of the bill, which was included in the original Republican draft and approved unanimously by Congress:


‘‘(a) IN GENERAL.—The United States Governor of the International Development Association is authorized to contribute on behalf of the United States $3,004,200,000 to the nineteenth replenishment of the resources of the Association, subject to obtaining the necessary appropriations.
‘‘(b) AUTHORIZATION OF APPROPRIATIONS.—In order to pay for the United States contribution provided for in subsection (a), there are authorized to be appropriated, without fiscal year limitation, $3,004,200,000 for payment by the Secretary of the Treasury.’’.
(2) INTERNATIONAL FINANCE CORPORATION AUTHORIZATION.— The International Finance Corporation Act (22 U.S.C. H. R. 748—314 282 et seq.) is amended by adding at the end the following new section:
‘‘(a) VOTES AUTHORIZED.—The United States Governor of the Corporation is authorized to vote in favor of—
‘‘(1) a resolution to increase the authorized capital stock of the Corporation by 16,999,998 shares, to implement the conversion of a portion of the retained earnings of the Corporation into paid-in capital, which will result in the United States being issued an additional 3,771,899 shares of capital stock, without any cash contribution;
‘‘(2) a resolution to increase the authorized capital stock of the Corporation on a general basis by 4,579,995 shares; and
‘‘(3) a resolution to increase the authorized capital stock of the Corporation on a selective basis by 919,998 shares.
‘‘(b) AMENDMENT OF THE ARTICLES OF AGREEMENT.—The United States Governor of the Corporation is authorized to agree to and accept an amendment to article II, section 2(c)(ii) of the Articles of Agreement of the Corporation that would increase the vote by which the Board of Governors of the Corporation may increase the capital stock of the Corporation from a four-fifths majority to an eighty-five percent majority.’’.
(3) AFRICAN DEVELOPMENT BANK.—The African Development Bank Act (22 U.S.C. 290i et seq.) is amended by adding at the end the following new section:
‘‘(1) IN GENERAL.—The United States Governor of the Bank may subscribe on behalf of the United States to 532,023 additional shares of the capital stock of the Bank.
‘‘(2) LIMITATION.—Any subscription by the United States to the capital stock of the Bank shall be effective only to such extent and in such amounts as are provided in advance in appropriations Acts.
‘‘(1) IN GENERAL.—In order to pay for the increase in the United States subscription to the Bank under subsection (a), there are authorized to be appropriated, without fiscal year limitation, $7,286,587,008 for payment by the Secretary of the Treasury.
‘‘(2) SHARE TYPES.—Of the amount authorized to be appropriated under paragraph (1)—
‘‘(A) $437,190,016 shall be for paid in shares of the Bank; and
‘‘(B) $6,849,396,992 shall be for callable shares of the Bank.’’.
(4) AFRICAN DEVELOPMENT FUND.—The African Development Fund Act (22 U.S.C. 290g et seq.) is amended by adding at the end the following new section:
‘‘(a) IN GENERAL.—The United States Governor of the Fund is authorized to contribute on behalf of the United States H.R. 748—315 $513,900,000 to the fifteenth replenishment of the resources of the Fund, subject to obtaining the necessary appropriations.
‘‘(b) AUTHORIZATION OF APPROPRIATIONS.—In order to pay for the United States contribution provided for in subsection (a), there are authorized to be appropriated, without fiscal year limitation, $513,900,000 for payment by the Secretary of the Treasury.’’.
(A) IN GENERAL.—Section 17 of the Bretton Woods Agreements Act (22 U.S.C. 286e–2) is amended—
(i) in subsection (a)—
(I) by redesignating paragraphs (3), (4), and
(5) as paragraphs (4), (5), and (6), respectively;
(II) by inserting after paragraph (2) the following new paragraph:
‘‘(3) In order to carry out the purposes of a one-time decision of the Executive Directors of the International Monetary Fund (the Fund) to expand the resources of the New Arrangements to Borrow, established pursuant to the decision of January 27, 1997, referred to in paragraph (1), the Secretary of the Treasury is authorized to make loans, in an amount not to exceed the dollar equivalent of 28,202,470,000 of Special Drawing Rights, in addition to any amounts previously authorized under this section, except that prior to activation of the New Arrangements to Borrow, the Secretary of the Treasury shall report to Congress whether supplementary resources are needed to forestall or cope with an impairment of the international monetary system and whether the Fund has fully explored other means of funding to the Fund.’’;
(III) in paragraph (5), as so re-designated, by striking ‘‘paragraph (3)’’ and inserting ‘‘paragraph (4)’’; and
(IV) in paragraph (6), as so re-designated, by striking ‘‘December 16, 2022’’ and inserting ‘‘December 31, 2025’’; and
(ii) in subsection (e)(1) by striking ‘‘(a)(2),’’ each place such term appears and inserting ‘‘(a)(2), (a)(3),’’.
(B) EMERGENCY DESIGNATION.—The amount provided by this paragraph is designated by the Congress as being for an emergency requirement pursuant to section
251(b)(2)(A)(i) of the Balanced Budget and Emergency Deficit Control Act of 1985.

Brem-V in WW2 was defeated without approval by the FDA

The World War reached a turning point in 1943 as the last of German troops at Stalingrad surrendered on January 31, but that celebration was soon forgotten, as some American officials learned of a new threat to our nation from the barbarians.

Tobacco Mosaic Virus

In a laboratory just outside Bremen, Germany, scientists had been studying new biological weapons, when they made a breakthrough in late 1942 by creating a deadly variant of the tobacco mosaic virus. It was named Brem-V.

After reviewing documents and making notes from an anonymous source, the story recalled here reveals a sinister plot that was thwarted by American resolve.

The virus was prepared in a liquid mixture, poured into small cologne perfume atomizers and sent through Switzerland into the United States, where the plan was to spray into the atmosphere at crowded events, and so the epidemic would begin.

Lab tests showed Brem-V was deadly, killing as many as 3% of those infected, and its symptoms were debilitating enough to keep victims in bed for at least two weeks if they survived. Should only 10 million got the infection, the 300,000 ensuing deaths would cause panic, shutdowns, even end much production of vital war materials.

On February 14th spies set the operation into motion in New York City’s Chinatown, as the virus was was released at three restaurants on two adjacent streets.

Within hours the White House learned of the attack and ordered a quiet tracking of those possibly affected. The virus was not extremely contagious, but it had a long period of gestation. The first step was a quarantine, extending 12 blocks in any direction. This area included about 8,000 residents.

Customs officials had intercepted one of the two shipments of the virus a week earlier. The government was already working on plans to fight a mass Brem-V epidemic if there were other virus bottles that had escaped detection.

Testing was vital. If those infected could be removed from the zone and treated off site, then life would return to normal in the neighborhood.

U.S. drug manufacturers had met with federal officials for several days, and none had tests that worked.

Flag of the KLA

Prior to the Nazi attack on the U.S., the Germans had tested the virus on occupied Korea. Patriots, working in secret, had devised a simple test kit to identify the virus with only a four-hour turnaround. By isolating the affected, many lives were saved and the Germans were unaware of the breakthrough.

The chemical details and schematics for the test were subsequently spirited off to the Korean Liberation Army (KLA), which was fighting in China against the Japanese invasion.

An American military officer at one of the early Brem-V task force sessions told the group that he heard the KLA had created a virus test that was both safe and fast. He was ordered to get more details and samples.

In two days the test kits arrived by plane from China. The FDA examined them, and reported:

While the KLA Test shows great promise, particularly because of anecdotal reports that these were used on several hundred patients in Korea without ill effects, such a test must require further examination by our agency. We would prefer a four-month, small group examination of efficacy and subsequent adverse reactions, followed by a seven-month regimen with a larger group, including subjects with and without the virus. Using information gained from these studies  we can make a recommendation after no more than a two-month review of the results.

This response from the Food and Drug folks was sent up the chain of command, ultimately to the White House, and a reply came back almost immediately to the task force:

We have much to fear from little men with great responsibility, and no war is won with cowardly sloth. Forget the bureaucrats, order 10,000 of the tests so we have some extras in case those SOB’s try this again.

-FDR, Feb. 16, 1943

Thanks to swift action, Brem-V was quickly eradicated by testing, isolating and treating for symptoms. Sadly, a handful of Americans died from the virus, but none from the testing.

No American drug company or medical device manufacturer was permitted to exploit the public with over-priced tests. The KLA donated the rights to formulas and methods – all for the sake of humanity.

Read how modern Korea’s Coronavirus $20 test was ignored here

Korean Liberation Army in WW2

FDA & NIAD guilty of incompetence, verging on treason!

Capitalism shows its most ugly face!

That ad is from eBay – plenty of paper for sale at five times the store price – 12 “mega” rolls for $59.99. Now you know why the “gangs” were fighting to clean off the grocery store shelves. For many buyers, it wasn’t need, but deplorable greed.

Here’s another ripoff on eBay:

Toilet paper at $10 a roll! Buy a big package at the store, separate it into single rolls and make yourself rich, despite the tribulations you cause others.

Desperate folks are even bidding for toilet paper. The above was from eBay this morning – $54.75 w/shipping for 12 rolls (34 bids).

An eBay search for toilet paper at 4 pm today found 3,613 auctions, plus 13,940 lots for Buy It Now purchase

Who is worse than greedy hucksters?

#1. Anthony S. Fauci, M.D.

Dr. Anthony Fauci

The Director of the National Institute of Allergy and Infectious Diseases (NIAD) since 1984, Fauci oversees “basic and applied research to prevent, diagnose, and treat established infectious diseases such as HIV/AIDS, respiratory infections, diarrheal diseases, tuberculosis and malaria as well as emerging diseases such as Ebola and Zika,” according to the NIAD website.

Fauci is a member of the White House Coronavirus Task Force established by President Donald Trump in late January.

As a member, on January 26 he claimed this about the coronavirus.

“It’s a very, very low risk to the United States,” Fauci said during an interview with radio show host John Catsimatidis.

But it’s something that we as public health officials need to take very seriously… It isn’t something the American public needs to worry about or be frightened about.

Because we have ways of preparing and screening of people coming in [from China]. And we have ways of responding – like we did with this one case in Seattle, Washington, who had traveled to China and brought back the infection.

On Wednesday, last week, he went into scare mode, suggesting that COVID-19 is considerably more dangerous than the flu:

The flu has a mortality rate of 0.1 percent. This has a mortality rate of 10 times that. That’s the reason I want to emphasize we have to stay ahead of the game in preventing this.

On this past Sunday’s Meet the Press Fauci warned that if the country fails to slow the trajectory, the number of domestic deaths could soar exponentially into the hundreds of thousands or even millions.

The worst is yet to come…to protect the American people, we’ll consider everything and anything on the table.

The Centers for Disease Control and Prevention estimate that between 20,000 to 52,000 Americans have died from influenza this season.

Using Fauci’s 10x premise, that means an uncontrolled COVID-19 epidemic would kill between 200,000 and 520,000 Americans.

Don’t believe it.

China, with nearly five times our population has only a total 3,300 deaths from the disease, and the epidemic there is nearly finished. China had only four new deaths and 36 new cases reported yesterday.

Using the China metric, the United States should expect 660 deaths, a tiny fraction of the tens of thousands of flu deaths projected by Fauci.

Fauci’s weekend reckless comments sent the stock market into free fall on Monday.

In my opinion Fauci is the number one culprit in our corona virus debacle by first minimizing the danger, then exaggerating it beyond credulous belief.

If you have comments about his performance or questions, this is his public contact information:

#2. Recent Commissioners of Food and Drug Administration (FDA)

Strict guidelines by the FDA have hampered development of testing methods in the United States, and the blame should be shared among the five commissioners appointed by President Trump in just his first term.

They each inherited a bad system, but didn’t fix it. The FDA rules stopped widespread test development until this month – much too late to identify victims and quarantine them effectively.

One example of FDA incompetence comes from Benjamin Pinsky, Medical Director of the Clinical Virology Laboratory at Stanford, who said his lab began working on a test in early February, following the overly strict FDA guidelines at the time.

When the FDA finally posted its more relaxed guidance, it took the Stanford lab only days to validate its test.

“We were waiting for the FDA to make a decision about how they would handle clinical laboratory testing,” Pinsky said.

My goal was to be prepared as soon as they were ready to allow clinical labs to start testing.

On March 2 Stanford got permission to begin testing. Before day’s end on March 4, Santa Clara County had already confirmed 14 cases. Too late! Results showed community spread was already underway.

A lab in San Francisco asked in early February if it could develop its own test under less extreme requirements, but the FDA refused, citing regulations:

Charles Chiu, associate director of the University of California at San Francisco Clinical Microbiology Laboratory, said:

We were trying to submit a clinical lab-developed test or develop a clinical test for emergency-use approval, and the issue with it was it was delayed, and that was because the FDA’s requirements were quite stringent.

The FDA was making it too laborious…it would take too long to actually get approval.

“I think that it would have been helpful had some of the new guidance come out earlier so that laboratories would have had more time, whereas now we’re scrambling to meet demand,” Chiu said.

If only we followed the lead of other nations, especially South Korea

There were 74 new coronavirus cases and no deaths reported in South Korea yesterday. The epidemic that struck 8,236 persons there has basically ended, leaving only 75 dead in a country of nearly 52 million.

If we experience a similar mortality rate, our deaths will be about 500 in a population of some 330 million.

South Korea put its labs and companies to work in January, and had effective test kits with four-hour results by early February.

Testing allows hot spots to be identified, affected citizens warned to take extra precautions and allows the healthcare system to focus efforts where most needed.

South Korea has tested 248,647 citizens, as of yesterday, compared to the U.S. total of 21,558.

More glaring is that South Korea has conducted 4,802 tests per million persons, compared to a minuscule 65 per million in this country – a disgrace for the supposed “best health care system in the world.”

Most other countries have a much higher rate of testing.

Review the table below, created here from analyzing World Health Organization statistics, and note the X million tests column.

America is doing worse at testing than not just South Korea, but also Bahrain, Iceland, Norway, Slovenia, Italy, Austria, Taiwan, Denmark, Russia, United Kingdom, Ireland, Netherlands, Australia, Canada, China, Czech Republic, Finland, Slovakia, Lithuania, Malaysia, France, Hungary, Croatia, Japan, Thailand, Armenia and New Zealand.